CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole |
|
Accession: | CHEBI:77260
|
browse the term
|
Definition: | A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5. |
Synonyms: | related_synonym: | Formula=C17H19N3O3S; InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20); InChIKey=SUBDBMMJDZJVOS-UHFFFAOYSA-N; SMILES=COc1ccc2[nH]c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C |
| xref: | CAS:73590-58-6; KEGG:C07324; KEGG:D00455 |
| xref_mesh: | MESH:D009853 |
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
Omeprazole results in increased expression of ABCA1 mRNA |
CTD |
PMID:20060385 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Omeprazole results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects expression multiple interactions |
EXP ISO |
Omeprazole affects the expression of ABCB1A mRNA Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1A protein] Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1 protein] |
CTD |
PMID:19483382 PMID:30452898 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
Omeprazole results in decreased expression of ABCB4 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Omeprazole results in increased susceptibility to Cisplatin] which results in decreased expression of ABCC2 protein |
CTD |
PMID:35447140 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
Omeprazole results in increased expression of ABCC3 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
affects expression |
EXP |
Omeprazole affects the expression of ABCC6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression multiple interactions |
ISO |
Omeprazole results in increased expression of ABCG2 mRNA alternative form; Omeprazole results in increased expression of ABCG2 protein Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow] |
CTD |
PMID:20804740 PMID:31348918 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
affects expression |
EXP |
Omeprazole affects the expression of ABCG5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
affects expression |
EXP |
Omeprazole affects the expression of ABHD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
affects expression |
EXP |
Omeprazole affects the expression of ABHD14B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Abhd17a |
abhydrolase domain containing 17A, depalmitoylase |
affects expression |
EXP |
Omeprazole affects the expression of ABHD17A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
affects expression |
EXP |
Omeprazole affects the expression of ACACA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
affects expression |
EXP |
Omeprazole affects the expression of ACADL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
decreases expression |
ISO EXP |
Omeprazole results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Aco1 |
aconitase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ACO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Aco2 |
aconitase 2 |
affects expression |
EXP |
Omeprazole affects the expression of ACO2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
affects expression |
EXP |
Omeprazole affects the expression of ACOT12 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
affects expression |
EXP |
Omeprazole affects the expression of ACOT4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
affects expression |
EXP |
Omeprazole affects the expression of ADAM15 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Add1 |
adducin 1 |
affects expression |
EXP |
Omeprazole affects the expression of ADD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
ISO |
Omeprazole results in decreased expression of ADH1C mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
affects expression |
EXP |
Omeprazole affects the expression of ADH4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
affects expression |
EXP |
Omeprazole affects the expression of ADTRP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Afm |
afamin |
affects expression |
EXP |
Omeprazole affects the expression of AFM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Agt |
angiotensinogen |
affects expression |
EXP |
Omeprazole affects the expression of AGT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
affects expression |
EXP |
Omeprazole affects the expression of AGTR1A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions decreases activity increases activity increases expression decreases expression affects localization increases response to substance |
EXP ISO |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] Omeprazole results in decreased activity of AHR protein Omeprazole results in increased activity of AHR protein Omeprazole results in increased expression of AHR protein Omeprazole results in decreased expression of AHR mRNA AG-879 inhibits the reaction [Omeprazole results in increased activity of AHR protein]; AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of AHR mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein]; Omeprazole binds to and results in increased activity of AHR protein; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; omeprazole sulfide inhibits the reaction [Omeprazole results in increased activity of AHR protein]; Puromycin inhibits the reaction [Omeprazole results in increased expression of AHR protein] Omeprazole affects the localization of AHR protein AHR protein results in increased susceptibility to Omeprazole |
CTD |
PMID:9139728 PMID:9395520 PMID:14742684 PMID:16109480 PMID:20171196 PMID:21703235 PMID:21861773 PMID:21924250 PMID:22687989 PMID:23850985 PMID:25797602 PMID:25826687 PMID:26187274 PMID:26272953 PMID:31669099 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
affects expression |
EXP |
Omeprazole affects the expression of AKR1A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
affects expression |
EXP |
Omeprazole affects the expression of AKR7A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of AKR7A3 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of ALDH1A1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
Omeprazole results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects expression |
EXP |
Omeprazole affects the expression of ALDH2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
Omeprazole results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alkbh7 |
alkB homolog 7 |
affects expression |
EXP |
Omeprazole affects the expression of ALKBH7 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:1,838,886...1,841,044
Ensembl chr 9:1,838,811...1,841,044
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
affects expression |
EXP |
Omeprazole affects the expression of AP2M1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Apcs |
amyloid P component, serum |
affects expression |
EXP |
Omeprazole affects the expression of APCS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
Omeprazole affects the expression of APOA4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoh |
apolipoprotein H |
affects expression |
EXP |
Omeprazole affects the expression of APOH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apool |
apolipoprotein O-like |
affects expression |
EXP |
Omeprazole affects the expression of APOOL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:77,377,723...77,443,672
Ensembl chr X:77,377,781...77,443,900
|
|
G |
Arg1 |
arginase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ARG1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arl6ip1 |
ARL6 interacting reticulophagy regulator 1 |
affects expression |
EXP |
Omeprazole affects the expression of ARL6IP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions affects localization |
ISO EXP |
Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter] Omeprazole affects the localization of ARNT protein Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] |
CTD |
PMID:9395520 PMID:21703235 PMID:25826687 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
affects expression |
EXP |
Omeprazole affects the expression of ASGR2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Atf5 |
activating transcription factor 5 |
affects expression |
EXP |
Omeprazole affects the expression of ATF5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
affects expression |
EXP |
Omeprazole affects the expression of ATP5F1E mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of ATP6AP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:10,183,983...10,210,948
Ensembl chr X:10,183,068...10,210,918
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
affects expression |
EXP |
Omeprazole affects the expression of ATP6V1A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atp6v1f |
ATPase H+ transporting V1 subunit F |
affects expression |
EXP |
Omeprazole affects the expression of ATP6V1F mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:58,067,666...58,070,628
|
|
G |
Atp7a |
ATPase copper transporting alpha |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein] Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein] |
CTD |
PMID:25337692 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of BAAT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of BAX protein] |
CTD |
PMID:30452898 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] |
CTD |
PMID:30452898 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
affects expression |
EXP |
Omeprazole affects the expression of BCL6B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bltp3b |
bridge-like lipid transfer protein family member 3B |
affects expression |
EXP |
Omeprazole affects the expression of BLTP3B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
|
|
G |
Bmf |
Bcl2 modifying factor |
affects expression |
EXP |
Omeprazole affects the expression of BMF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmx |
BMX non-receptor tyrosine kinase |
multiple interactions |
ISO |
BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein] |
CTD |
PMID:21861773 |
|
NCBI chr X:30,227,251...30,290,015
Ensembl chr X:30,227,251...30,289,993
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
affects expression |
EXP |
Omeprazole affects the expression of BNIP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Btf3 |
basic transcription factor 3 |
affects expression |
EXP |
Omeprazole affects the expression of BTF3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
Omeprazole results in decreased expression of C1QA mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qbp |
complement C1q binding protein |
affects expression |
EXP |
Omeprazole affects the expression of C1QBP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
Omeprazole results in decreased expression of C1QC mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1s |
complement C1s |
affects expression |
EXP |
Omeprazole affects the expression of C1S mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
affects expression |
EXP |
Omeprazole affects the expression of C2CD2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
affects expression decreases expression |
EXP |
Omeprazole affects the expression of C4BPA mRNA Omeprazole results in decreased expression of C4BPA mRNA |
CTD |
PMID:19483382 PMID:25626140 |
|
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
decreases expression |
EXP |
Omeprazole results in decreased expression of C4BPB mRNA |
CTD |
PMID:25626140 |
|
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C7 |
complement C7 |
affects expression |
EXP |
Omeprazole affects the expression of C7 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8b |
complement C8 beta chain |
affects expression |
EXP |
Omeprazole affects the expression of C8B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:119,535,009...119,572,565
Ensembl chr 5:119,535,146...119,572,565
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
affects expression |
EXP |
Omeprazole affects the expression of CADPS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:51,780,415...52,309,641
Ensembl chr 4:51,781,053...52,309,829
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CAPRIN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Car2 |
carbonic anhydrase 2 |
affects expression |
EXP |
Omeprazole affects the expression of CA2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car3 |
carbonic anhydrase 3 |
affects expression |
EXP |
Omeprazole affects the expression of CAR3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions affects expression increases cleavage |
ISO EXP |
Omeprazole analog results in increased activity of CASP3 protein; Omeprazole results in increased activity of CASP3 protein Omeprazole inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] Omeprazole inhibits the reaction [Ethanol results in increased activity of CASP3 protein]; Omeprazole inhibits the reaction [Ethanol results in increased expression of CASP3 mRNA]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of CASP3 protein] Omeprazole affects the expression of CASP3 mRNA Omeprazole results in increased cleavage of CASP3 protein |
CTD |
PMID:15461867 PMID:18336733 PMID:19251492 PMID:19483382 PMID:25637687 PMID:30452898 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
Omeprazole analog results in increased cleavage of CASP8 protein |
CTD |
PMID:18336733 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP ISO |
Omeprazole results in increased activity of CAT protein Omeprazole inhibits the reaction [Ethanol results in decreased activity of CAT protein] Omeprazole inhibits the reaction [Acetic Acid results in increased activity of CAT protein] |
CTD |
PMID:18547560 PMID:28849987 PMID:33245926 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CBR1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cckbr |
cholecystokinin B receptor |
multiple interactions |
ISO |
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3 |
CTD |
PMID:17704804 |
|
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
Omeprazole results in decreased expression of CCND1 mRNA |
CTD |
PMID:17202759 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Omeprazole results in increased expression of CDKN1A protein |
CTD |
PMID:27358234 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
affects expression |
EXP |
Omeprazole affects the expression of CDO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CEPT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578
|
|
G |
Ces2h |
carboxylesterase 2H |
affects expression |
EXP |
Omeprazole affects the expression of CES2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfi |
complement factor I |
affects expression decreases expression |
EXP |
Omeprazole affects the expression of CFI mRNA Omeprazole results in decreased expression of CFI mRNA |
CTD |
PMID:19483382 PMID:25626140 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cftr |
CF transmembrane conductance regulator |
affects metabolic processing |
ISO |
CFTR protein affects the metabolism of Omeprazole |
CTD |
PMID:15319328 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CHP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
affects expression |
EXP |
Omeprazole affects the expression of CISD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
affects expression |
EXP |
Omeprazole affects the expression of CLCN4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
affects expression |
EXP |
Omeprazole affects the expression of CLPP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
|
|
G |
Clptm1l |
CLPTM1-like |
affects expression |
EXP |
Omeprazole affects the expression of CLPTM1L mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
affects expression |
EXP |
Omeprazole affects the expression of CMBL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CMPK1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
affects expression |
EXP |
Omeprazole affects the expression of COPG1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Cops4 |
COP9 signalosome subunit 4 |
affects expression |
EXP |
Omeprazole affects the expression of COPS4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of COQ3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
affects expression |
EXP |
Omeprazole affects the expression of COX4I1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpn1 |
carboxypeptidase N subunit 1 |
affects expression |
EXP |
Omeprazole affects the expression of CPN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
|
|
G |
Cpq |
carboxypeptidase Q |
affects expression |
EXP |
Omeprazole affects the expression of CPQ mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Crem |
cAMP responsive element modulator |
affects expression |
EXP |
Omeprazole affects the expression of CREM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Csnk2b |
casein kinase 2 beta |
affects expression |
EXP |
Omeprazole affects the expression of CSNK2B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CSRP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctnna1 |
catenin alpha 1 |
affects expression |
EXP |
Omeprazole affects the expression of CTNNA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctsb |
cathepsin B |
decreases activity |
ISO |
Omeprazole results in decreased activity of CTSB protein |
CTD |
PMID:34871754 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein] |
CTD |
PMID:20165931 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctse |
cathepsin E |
decreases expression |
EXP |
Omeprazole results in decreased expression of CTSE |
CTD |
PMID:7575556 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression multiple interactions |
ISO |
Omeprazole results in decreased expression of CXCR4 mRNA AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA] |
CTD |
PMID:25826687 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity decreases activity |
ISO EXP |
AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter] Omeprazole inhibits the reaction [Oxygen results in increased expression of CYP1A1 protein]; Omeprazole promotes the reaction [Oxygen results in decreased expression of CYP1A1 mRNA] Omeprazole results in increased expression of CYP1A1 mRNA; Omeprazole results in increased expression of CYP1A1 protein Omeprazole results in increased activity of CYP1A1 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; lavendustin A inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Staurosporine inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Tosyllysine Chloromethyl Ketone inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA] Omeprazole results in decreased activity of CYP1A1 protein Omeprazole results in increased activity of CYP1A1 promoter |
CTD |
PMID:8647108 PMID:8900397 PMID:9041675 PMID:9139728 PMID:9152597 PMID:9395520 PMID:9860486 PMID:10103034 PMID:10859152 PMID:11454723 PMID:11849738 PMID:12040753 PMID:12623754 PMID:12841937 PMID:14742684 PMID:14987951 PMID:15681896 PMID:15860653 PMID:17202759 PMID:17954527 PMID:18420780 PMID:18502397 PMID:19118567 PMID:20171196 PMID:21666223 PMID:21703235 PMID:21784029 PMID:22687989 PMID:25626140 PMID:25826687 PMID:26187180 PMID:26272953 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases expression increases activity |
ISO EXP |
Omeprazole results in decreased activity of CYP1A2 protein [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA Omeprazole results in increased activity of CYP1A2 promoter; Omeprazole results in increased activity of CYP1A2 protein |
CTD |
PMID:9152597 PMID:9744552 PMID:12040753 PMID:12623754 PMID:12841937 PMID:15681896 PMID:15802389 PMID:16035375 PMID:17954527 PMID:18332078 PMID:18420780 PMID:18502397 PMID:19118567 PMID:19230594 PMID:20171196 PMID:21784029 PMID:21924250 PMID:22524704 PMID:22687989 PMID:23274770 PMID:23850985 PMID:24752503 PMID:25626140 PMID:26204831 PMID:27794450 PMID:30044681 PMID:31863871 PMID:36288780 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions affects expression increases expression decreases activity |
ISO |
Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter] Omeprazole affects the expression of CYP1B1 mRNA Omeprazole results in increased expression of CYP1B1 mRNA Omeprazole results in decreased activity of CYP1B1 protein |
CTD |
PMID:12040753 PMID:12623754 PMID:18420780 PMID:21703235 PMID:25826687 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Omeprazole results in increased expression of CYP2B1 mRNA; Omeprazole results in increased expression of CYP2B1 protein |
CTD |
PMID:9152597 PMID:19118567 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
affects expression increases expression |
EXP |
Omeprazole affects the expression of CYP2B2 mRNA Omeprazole results in increased expression of CYP2B2 protein |
CTD |
PMID:9152597 PMID:19483382 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects expression decreases activity increases expression increases activity |
EXP ISO |
Omeprazole affects the expression of CYP2B3 mRNA Omeprazole results in decreased activity of CYP2B10 protein Omeprazole results in increased expression of CYP2B6 mRNA Omeprazole results in increased activity of CYP2B6 protein |
CTD |
PMID:17954527 PMID:18420780 PMID:19118567 PMID:19483382 PMID:22524704 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
affects metabolic processing decreases activity multiple interactions increases metabolic processing decreases metabolic processing increases hydroxylation |
ISO |
CYP2C19 protein affects the metabolism of Omeprazole Omeprazole results in decreased activity of CYP2C19 protein [5-bromotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-chlorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [7-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Chloramphenicol results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Fluconazole results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [indopan results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of Aconitine metabolite; [Tryptamines analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; Omeprazole affects the reaction [CYP2C19 protein affects the metabolism of Warfarin]; Omeprazole inhibits the reaction [CYP2C19 protein results in decreased methylation of adinazolam]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased chemical synthesis of 4-hydroxymephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased hydroxylation of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of auriculasin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Fluoxetine]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of 2-oxo-clopidogrel]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of Clopidogrel] CYP2C19 protein results in increased metabolism of Omeprazole CYP2C19 gene alternative form results in decreased metabolism of Omeprazole CYP2C19 protein results in increased hydroxylation of Omeprazole |
CTD |
PMID:8930576 PMID:9600717 PMID:11752104 PMID:12464242 PMID:12467917 PMID:12485723 PMID:12637241 PMID:14586384 PMID:15258107 PMID:15286053 PMID:15306208 PMID:15626586 PMID:16035375 PMID:17565714 PMID:17702393 PMID:18511451 PMID:18520598 PMID:19812348 PMID:20573087 PMID:21277363 PMID:21795468 PMID:21915887 PMID:22634058 PMID:26599973 PMID:31515991 More...
|
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2D3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
affects expression decreases activity |
EXP ISO |
Omeprazole affects the expression of CYP2D4 mRNA Omeprazole results in decreased activity of CYP2D6 protein |
CTD |
PMID:18420780 PMID:19483382 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
Omeprazole results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:15802389 PMID:36243147 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2F4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2J4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2T1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression increases metabolic processing affects metabolic processing |
ISO |
[Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; NR1I2 protein affects the reaction [Omeprazole results in increased expression of CYP3A4 mRNA]; Omeprazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Omeprazole results in increased expression of and results in increased activity of CYP3A4 protein Omeprazole results in increased expression of CYP3A4 mRNA; Omeprazole results in increased expression of CYP3A4 protein CYP3A4 protein results in increased metabolism of Omeprazole CYP3A4 protein affects the metabolism of Omeprazole |
CTD |
PMID:7870052 PMID:8930576 PMID:9744552 PMID:12235278 PMID:12485723 PMID:12695340 PMID:15286053 PMID:15466163 PMID:15626586 PMID:15802389 PMID:17041008 PMID:17565714 PMID:17954527 PMID:19118567 PMID:19299527 PMID:22634058 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
affects expression increases expression |
EXP |
Omeprazole affects the expression of CYP3A23-3A1 mRNA Omeprazole results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:19118567 PMID:19483382 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects expression increases expression |
EXP ISO |
Omeprazole affects the expression of CYP3A9 mRNA Omeprazole results in increased expression of CYP3A5 mRNA |
CTD |
PMID:19118567 PMID:19483382 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
affects expression |
EXP |
Omeprazole affects the expression of CYP4A8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
affects expression |
EXP |
Omeprazole affects the expression of CYP4F6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Dbi |
diazepam binding inhibitor |
affects expression |
EXP |
Omeprazole affects the expression of DBI mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
affects expression |
EXP |
Omeprazole affects the expression of DCAF11 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
affects expression |
EXP |
Omeprazole affects the expression of DCXR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Omeprazole results in increased expression of DDIT3 protein |
CTD |
PMID:27358234 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
affects expression |
EXP |
Omeprazole affects the expression of DECR1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dexi |
Dexi homolog |
affects expression |
EXP |
Omeprazole affects the expression of DEXI mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of DGAT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
affects expression |
EXP |
Omeprazole affects the expression of DHCR24 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
affects expression |
EXP |
Omeprazole affects the expression of DHRS4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
affects expression |
EXP |
Omeprazole affects the expression of DHRS7B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhx16 |
DEAH-box helicase 16 |
affects expression |
EXP |
Omeprazole affects the expression of DHX16 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:2,862,000...2,874,991
Ensembl chr20:2,862,000...2,874,948
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
affects expression |
EXP |
Omeprazole affects the expression of DMAC2L mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
affects expression |
EXP |
Omeprazole affects the expression of DNAJC3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
affects expression |
EXP |
Omeprazole affects the expression of DPP4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of DPYD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Ears2 |
glutamyl-tRNA synthetase 2, mitochondrial |
affects expression |
EXP |
Omeprazole affects the expression of EARS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:176,597,986...176,625,848
Ensembl chr 1:176,597,986...176,625,836
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
affects expression |
EXP |
Omeprazole affects the expression of ECHS1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ECI1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
affects expression |
EXP |
Omeprazole affects the expression of ECI2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
affects expression |
EXP |
Omeprazole affects the expression of EEF1G mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Omeprazole promotes the reaction [Indomethacin results in increased expression of EGF protein] |
CTD |
PMID:18431645 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of EHHADH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
affects expression |
EXP |
Omeprazole affects the expression of EIF4A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of EIF4EBP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4h |
eukaryotic translation initiation factor 4H |
affects expression |
EXP |
Omeprazole affects the expression of EIF4H mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENC1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Eno1 |
enolase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Enpep |
glutamyl aminopeptidase |
affects expression |
EXP |
Omeprazole affects the expression of ENPEP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENPP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter] |
CTD |
PMID:21703235 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epcam |
epithelial cell adhesion molecule |
affects expression |
EXP |
Omeprazole affects the expression of EPCAM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
affects expression |
EXP |
Omeprazole affects the expression of ERP29 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Esd |
esterase D |
affects expression |
EXP |
Omeprazole affects the expression of ESD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of ETFB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
|
|
G |
Faah |
fatty acid amide hydrolase |
affects expression |
EXP |
Omeprazole affects the expression of FAAH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fads2 |
fatty acid desaturase 2 |
affects expression |
EXP |
Omeprazole affects the expression of FADS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FBP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FDFT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
affects expression |
EXP |
Omeprazole affects the expression of FDPS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fdx2 |
ferredoxin 2 |
affects expression |
EXP |
Omeprazole affects the expression of FDX2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:19,604,916...19,609,832
Ensembl chr 8:19,604,916...19,609,849
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FMO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of GAMT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of GAPDH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gast |
gastrin |
increases expression |
ISO EXP |
Omeprazole results in increased expression of GAST protein |
CTD |
PMID:11422300 PMID:12189558 PMID:12763636 PMID:15223672 PMID:16618411 PMID:17652263 More...
|
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
affects expression |
EXP |
Omeprazole affects the expression of GBE1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
affects expression |
EXP |
Omeprazole affects the expression of GCHFR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
affects expression |
EXP |
Omeprazole affects the expression of GGH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GGT1 mRNA |
CTD |
PMID:22687989 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
affects expression |
EXP |
Omeprazole affects the expression of GJB1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
affects expression |
EXP |
Omeprazole affects the expression of GPLD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects expression |
EXP |
Omeprazole affects the expression of GPX1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA |
CTD |
PMID:22687989 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
affects expression |
EXP |
Omeprazole affects the expression of GPX4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of GRINA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
affects expression |
EXP |
Omeprazole affects the expression of GRPEL1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions increases expression |
EXP |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA Omeprazole results in increased expression of GSTA5 mRNA |
CTD |
PMID:17202759 PMID:22687989 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Omeprazole results in increased expression of GSTP1 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
affects expression |
EXP |
Omeprazole affects the expression of GSTT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
affects expression |
EXP |
Omeprazole affects the expression of GTF2H5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gzma |
granzyme A |
affects expression |
EXP |
Omeprazole affects the expression of GZMA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
H3f3b |
H3.3 histone B |
affects expression |
EXP |
Omeprazole affects the expression of H3F3B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709 Ensembl chr13:101,256,480...101,258,709
|
|
G |
Hal |
histidine ammonia lyase |
affects expression |
EXP |
Omeprazole affects the expression of HAL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
increases secretion multiple interactions increases expression |
ISO |
Omeprazole results in increased secretion of HAMP protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA] Omeprazole results in increased expression of HAMP mRNA; Omeprazole results in increased expression of HAMP protein |
CTD |
PMID:31669099 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
affects expression |
EXP |
Omeprazole affects the expression of HAO2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
affects expression |
EXP |
Omeprazole affects the expression of HBA-A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbb |
hemoglobin subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of HBB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hdc |
histidine decarboxylase |
affects expression increases expression increases stability multiple interactions |
EXP |
Omeprazole affects the expression of HDC mRNA Omeprazole results in increased expression of HDC mRNA Omeprazole results in increased stability of HDC protein Omeprazole results in increased expression of and results in increased activity of HDC protein |
CTD |
PMID:12763636 PMID:19483382 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
affects expression |
EXP |
Omeprazole affects the expression of HGD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
|
|
G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
affects expression |
EXP |
Omeprazole affects the expression of HMGN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:35,422,328...35,428,247
Ensembl chr11:35,422,328...35,428,254
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
Omeprazole results in increased expression of HMOX1 mRNA; Omeprazole results in increased expression of HMOX1 protein Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein]; Omeprazole results in increased expression of and results in increased activity of HMOX1 protein |
CTD |
PMID:16712795 PMID:27725188 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of HPRT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hps5 |
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2 |
affects expression |
EXP |
Omeprazole affects the expression of HPS5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:97,281,626...97,320,945
Ensembl chr 1:97,247,598...97,321,019
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
affects expression |
EXP |
Omeprazole affects the expression of HSD17B4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
affects expression |
EXP |
Omeprazole affects the expression of HSDL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions decreases expression |
EXP |
Zinc Compounds analog inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein]; Zinc Sulfate inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein] Omeprazole results in decreased expression of HSPA1A mRNA; Omeprazole results in decreased expression of HSPA1A protein |
CTD |
PMID:15223672 PMID:16945336 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] |
CTD |
PMID:25637687 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
affects expression |
EXP |
Omeprazole affects the expression of HTRA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
ISO |
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3 |
CTD |
PMID:17704804 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] |
CTD |
PMID:19232345 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
EXP |
Omeprazole affects the expression of IGF1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
affects expression |
EXP |
Omeprazole affects the expression of IGFALS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of IGFBP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL10 protein] |
CTD |
PMID:26970604 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL1B protein] |
CTD |
PMID:32418911 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL6 protein]; Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL6 protein] |
CTD |
PMID:25637687 PMID:32418911 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Impa1 |
inositol monophosphatase 1 |
affects expression |
EXP |
Omeprazole affects the expression of IMPA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
|
|
G |
Inhbe |
inhibin subunit beta E |
affects expression |
EXP |
Omeprazole affects the expression of INHBE mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ISYNA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
affects expression |
EXP |
Omeprazole affects the expression of ITIH4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jak1 |
Janus kinase 1 |
affects expression |
EXP |
Omeprazole affects the expression of JAK1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Kdelr2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
affects expression |
EXP |
Omeprazole affects the expression of KDELR2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
|
|
G |
Kdr |
kinase insert domain receptor |
affects expression multiple interactions |
EXP ISO |
Omeprazole affects the expression of KDR mRNA Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein] |
CTD |
PMID:19483382 PMID:26272953 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Krt8 |
keratin 8 |
affects expression |
EXP |
Omeprazole affects the expression of KRT8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of LCAT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of LCMT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
|
|
G |
Lipc |
lipase C, hepatic type |
affects expression |
EXP |
Omeprazole affects the expression of LIPC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lox |
lysyl oxidase |
affects expression |
EXP |
Omeprazole affects the expression of LOX mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrp3 |
LDL receptor related protein 3 |
affects expression |
EXP |
Omeprazole affects the expression of LRP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:87,843,815...87,859,147
Ensembl chr 1:87,844,868...87,859,110
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
affects expression |
EXP |
Omeprazole affects the expression of MAN2B1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
affects expression |
EXP |
Omeprazole affects the expression of MAP2K2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:17406807 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Masp2 |
MBL associated serine protease 2 |
affects expression |
EXP |
Omeprazole affects the expression of MASP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
|
|
G |
Me1 |
malic enzyme 1 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of ME1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Indomethacin results in decreased expression of MMP14 protein] |
CTD |
PMID:16934674 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Hydrogen Peroxide results in decreased activity of MMP2 protein] |
CTD |
PMID:16934674 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
affects expression |
EXP |
Omeprazole affects the expression of MMUT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions decreases activity |
ISO EXP |
Omeprazole inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Acids results in increased activity of MPO protein] Omeprazole results in decreased activity of MPO protein Omeprazole inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Cysteamine results in increased expression of MPO protein]; Omeprazole inhibits the reaction [Ethanol results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of MPO protein] |
CTD |
PMID:16091555 PMID:17151854 PMID:20165931 PMID:25637687 PMID:27780710 PMID:29770154 PMID:31095933 PMID:33245926 More...
|
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mro |
maestro |
affects expression |
EXP |
Omeprazole affects the expression of MRO mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
|
|
G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
affects expression |
EXP |
Omeprazole affects the expression of MRPL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:14,333,233...14,337,006
Ensembl chr 9:14,333,234...14,337,040
|
|
G |
mrpl9 |
mitochondrial ribosomal protein L9 |
affects expression |
EXP |
Omeprazole affects the expression of MRPL9 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:182,082,012...182,086,758
Ensembl chr 2:182,076,369...182,087,095
|
|
G |
Mug2 |
murinoglobulin 2 |
affects expression |
EXP |
Omeprazole affects the expression of PZP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
|
|
G |
Myadm |
myeloid-associated differentiation marker |
affects expression |
EXP |
Omeprazole affects the expression of MYADM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Mycbp2 |
MYC binding protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of MYCBP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
|
|
G |
Myo1d |
myosin ID |
affects expression |
EXP |
Omeprazole affects the expression of MYO1D mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
|
|
G |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
affects expression |
EXP |
Omeprazole affects the expression of NAA38 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
affects expression |
EXP |
Omeprazole affects the expression of NAP1L1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Nat8 |
N-acetyltransferase 8 |
affects expression |
EXP |
Omeprazole affects the expression of NAT8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter] |
CTD |
PMID:21703235 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ndrg2 |
NDRG family member 2 |
affects expression |
EXP |
Omeprazole affects the expression of NDRG2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Ndufs5 |
NADH:ubiquinone oxidoreductase subunit S5 |
affects expression |
EXP |
Omeprazole affects the expression of NDUFS5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:135,974,029...135,979,705
Ensembl chr 5:135,974,034...135,979,603 Ensembl chr14:135,974,034...135,979,603 Ensembl chr 2:135,974,034...135,979,603
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
affects expression |
EXP |
Omeprazole affects the expression of NDUFV3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Neu2 |
neuraminidase 2 |
affects expression |
EXP |
Omeprazole affects the expression of NEU2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:88,218,494...88,267,356
Ensembl chr 9:88,249,135...88,267,355
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] |
CTD |
PMID:27725188 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of NFKBIA protein] |
CTD |
PMID:32418911 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
affects expression |
EXP |
Omeprazole affects the expression of NFX1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
|
|
G |
Nipal2 |
NIPA-like domain containing 2 |
affects expression |
EXP |
Omeprazole affects the expression of NIPAL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:65,774,477...65,884,807
Ensembl chr 7:65,774,477...65,884,807
|
|
G |
Nit1 |
nitrilase 1 |
affects expression |
EXP |
Omeprazole affects the expression of NIT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein] |
CTD |
PMID:32418911 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
affects expression |
EXP |
Omeprazole affects the expression of NME2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
EXP ISO |
Omeprazole results in increased expression of NQO1 mRNA Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 protein] [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA |
CTD |
PMID:17202759 PMID:22687989 PMID:26272953 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO EXP |
[Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; NR1I2 protein affects the reaction [Omeprazole results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:12695340 PMID:17041008 PMID:25680588 PMID:26187274 PMID:27732639 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects expression decreases metabolic processing increases expression |
EXP ISO |
Omeprazole affects the expression of NR1I3 mRNA NR1I3 gene mutant form results in decreased metabolism of Omeprazole Omeprazole results in increased expression of NR1I3 mRNA |
CTD |
PMID:19118567 PMID:19483382 PMID:27434302 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects expression |
EXP |
Omeprazole affects the expression of NR3C1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Oaf |
out at first homolog |
affects expression |
EXP |
Omeprazole affects the expression of OAF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
affects expression |
EXP |
Omeprazole affects the expression of OBP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of OGDH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Olr59 |
olfactory receptor 59 |
affects expression |
EXP |
Omeprazole affects the expression of OLR59 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Ostc |
oligosaccharyltransferase complex non-catalytic subunit |
affects expression |
EXP |
Omeprazole affects the expression of OSTC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
|
|
G |
Otc |
ornithine transcarbamylase |
affects expression |
EXP |
Omeprazole affects the expression of OTC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
affects expression |
EXP |
Omeprazole affects the expression of PABPC4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:135,563,142...135,578,985
Ensembl chr 5:135,563,562...135,578,979
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
affects expression |
EXP |
Omeprazole affects the expression of PAICS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Omeprazole results in increased cleavage of PARP1 protein |
CTD |
PMID:15461867 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pc |
pyruvate carboxylase |
affects expression |
EXP |
Omeprazole affects the expression of PCX mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pccb |
propionyl-CoA carboxylase subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of PCCB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:101,590,737...101,641,234
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP ISO |
[Omeprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of PCNA protein]; Omeprazole promotes the reaction [Acetic Acid results in increased expression of PCNA protein] Omeprazole inhibits the reaction [Ethanol results in decreased expression of PCNA protein] |
CTD |
PMID:19251492 PMID:26970604 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
affects expression |
EXP |
Omeprazole affects the expression of PCSK6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
affects expression |
EXP |
Omeprazole affects the expression of PCTP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
|
|
G |
Pdcl3 |
phosducin-like 3 |
affects expression |
EXP |
Omeprazole affects the expression of PDCL3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:41,234,322...41,243,769
Ensembl chr 9:41,234,234...41,243,735
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
affects expression |
EXP |
Omeprazole affects the expression of PDIA3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
affects expression |
EXP |
Omeprazole affects the expression of PDIA6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Pex19 |
peroxisomal biogenesis factor 19 |
affects expression |
EXP |
Omeprazole affects the expression of PEX19 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
affects expression |
EXP |
Omeprazole affects the expression of PGAM1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgrmc1 |
progesterone receptor membrane component 1 |
affects expression |
EXP |
Omeprazole affects the expression of PGRMC1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
affects expression |
EXP |
Omeprazole affects the expression of PHYH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
|
|
G |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
affects expression |
EXP |
Omeprazole affects the expression of PIGP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:33,682,943...33,689,111
Ensembl chr11:33,682,948...33,689,321
|
|
G |
Pklr |
pyruvate kinase L/R |
affects expression |
EXP |
Omeprazole affects the expression of PKLR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
increases phosphorylation multiple interactions |
ISO |
Omeprazole results in increased phosphorylation of PLA2G4A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Omeprazole results in increased phosphorylation of PLA2G4A protein] |
CTD |
PMID:25797602 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
affects expression |
EXP |
Omeprazole affects the expression of PLBD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
|
|
G |
Plg |
plasminogen |
affects expression |
EXP |
Omeprazole affects the expression of PLG mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Pls3 |
plastin 3 |
affects expression |
EXP |
Omeprazole affects the expression of PLS3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
|
|
G |
Pon2 |
paraoxonase 2 |
affects expression |
EXP |
Omeprazole affects the expression of PON2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Pou2f2 |
POU class 2 homeobox 2 |
multiple interactions |
ISO EXP |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of POU2F2 protein] |
CTD |
PMID:30452898 |
|
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
|
|
G |
Ppdpf |
pancreatic progenitor cell differentiation and proliferation factor |
affects expression |
EXP |
Omeprazole affects the expression of PPDPF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:168,299,309...168,301,040
Ensembl chr 3:168,299,791...168,301,036
|
|
G |
Prdx2 |
peroxiredoxin 2 |
affects expression |
EXP |
Omeprazole affects the expression of PRDX2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx6 |
peroxiredoxin 6 |
affects expression |
EXP |
Omeprazole affects the expression of PRDX6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prl |
prolactin |
increases expression |
ISO |
Omeprazole results in increased expression of PRL protein |
CTD |
PMID:20726208 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
affects expression |
EXP |
Omeprazole affects the expression of PROC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Prpsap1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of PRPSAP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:101,701,094...101,750,753
Ensembl chr10:101,701,096...101,750,751
|
|
G |
Psma6 |
proteasome 20S subunit alpha 6 |
affects expression |
EXP |
Omeprazole affects the expression of PSMA6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
|
|
G |
Psmb1 |
proteasome 20S subunit beta 1 |
affects expression |
EXP |
Omeprazole affects the expression of PSMB1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
affects expression |
EXP |
Omeprazole affects the expression of PSMB3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
|
|
G |
Psmc1 |
proteasome 26S subunit, ATPase 1 |
affects expression |
EXP |
Omeprazole affects the expression of PSMC1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:119,392,833...119,405,233
Ensembl chr 6:119,392,855...119,410,123
|
|
G |
Psmc3 |
proteasome 26S subunit, ATPase 3 |
affects expression |
EXP |
Omeprazole affects the expression of PSMC3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
affects expression |
EXP |
Omeprazole affects the expression of PSMC5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Psmd1 |
proteasome 26S subunit, non-ATPase 1 |
affects expression |
EXP |
Omeprazole affects the expression of PSMD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211
|
|
G |
Psmd4 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 4 |
affects expression |
EXP |
Omeprazole affects the expression of PSMD4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:182,598,934...182,608,250
Ensembl chr 2:182,598,934...182,608,194
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
[Omeprazole co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA; [Omeprazole co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein Omeprazole inhibits the reaction [Ethanol results in increased expression of PTGS2 protein] |
CTD |
PMID:23038005 PMID:26970604 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptms |
parathymosin |
affects expression |
EXP |
Omeprazole affects the expression of PTMS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
affects expression |
EXP |
Omeprazole affects the expression of PTPRF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Pttg1ip |
PTTG1 interacting protein |
affects expression |
EXP |
Omeprazole affects the expression of PTTG1IP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:11,030,013...11,047,742
Ensembl chr20:11,030,015...11,047,316
|
|
G |
Pygl |
glycogen phosphorylase L |
affects expression |
EXP |
Omeprazole affects the expression of PYGL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Rab5if |
RAB5 interacting factor |
affects expression |
EXP |
Omeprazole affects the expression of RAB5IF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:145,357,990...145,368,012
Ensembl chr 3:145,357,861...145,368,012
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
[Omeprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of RELA protein]; Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein] Omeprazole inhibits the reaction [Cisplatin affects the localization of RELA protein] |
CTD |
PMID:19251492 PMID:30452898 PMID:32418911 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retsat |
retinol saturase |
increases expression |
EXP |
Omeprazole results in increased expression of RETSAT mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
affects expression |
EXP |
Omeprazole affects the expression of RIDA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Rnase4 |
ribonuclease A family member 4 |
affects expression |
EXP |
Omeprazole affects the expression of RNASE4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:24,312,765...24,330,112
Ensembl chr15:24,312,464...24,330,117
|
|
G |
Rnf103 |
ring finger protein 103 |
affects expression |
EXP |
Omeprazole affects the expression of RNF103 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
|
|
G |
Rnps1 |
RNA binding protein with serine rich domain 1 |
affects expression |
EXP |
Omeprazole affects the expression of RNPS1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:13,445,516...13,455,858
Ensembl chr10:13,445,653...13,455,858
|
|
G |
Rpl11 |
ribosomal protein L11 |
affects expression |
EXP |
Omeprazole affects the expression of RPL11 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
|
|
G |
Rpl13 |
ribosomal protein L13 |
affects expression |
EXP |
Omeprazole affects the expression of RPL13 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
|
|
G |
Rpl15 |
ribosomal protein L15 |
affects expression |
EXP |
Omeprazole affects the expression of RPL15 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:7,503,883...7,507,166
Ensembl chr15:7,503,883...7,507,165 Ensembl chr12:7,503,883...7,507,165
|
|
G |
Rpl17 |
ribosomal protein L17 |
affects expression |
EXP |
Omeprazole affects the expression of RPL17 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253 Ensembl chr 3:68,581,098...68,584,253
|
|
G |
Rpl23 |
ribosomal protein L23 |
affects expression |
EXP |
Omeprazole affects the expression of RPL23 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:82,771,878...82,775,840
Ensembl chr10:82,771,538...82,775,870
|
|
G |
Rpl3 |
ribosomal protein L3 |
affects expression |
EXP |
Omeprazole affects the expression of RPL3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468
|
|
G |
Rpl32 |
ribosomal protein L32 |
affects expression |
EXP |
Omeprazole affects the expression of RPL32 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:148,864,048...148,867,612
Ensembl chr 4:148,864,044...148,867,612 Ensembl chr 3:148,864,044...148,867,612
|
|
G |
Rpl4 |
ribosomal protein L4 |
affects expression |
EXP |
Omeprazole affects the expression of RPL4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:64,671,177...64,676,301
Ensembl chr 8:64,671,160...64,676,306
|
|
G |
Rpn2 |
ribophorin II |
affects expression |
EXP |
Omeprazole affects the expression of RPN2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:145,941,787...145,989,271
Ensembl chr 3:145,941,839...145,989,543
|
|
G |
Rps14 |
ribosomal protein S14 |
affects expression |
EXP |
Omeprazole affects the expression of RPS14 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:54,227,854...54,232,638
Ensembl chr18:54,227,854...54,233,166
|
|
G |
Rps18 |
ribosomal protein S18 |
affects expression |
EXP |
Omeprazole affects the expression of RPS18 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:4,931,427...4,935,538
Ensembl chr20:4,931,768...4,938,315
|
|
G |
Rps19 |
ribosomal protein S19 |
affects expression |
EXP |
Omeprazole affects the expression of RPS19 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508 Ensembl chr 7:80,480,951...80,486,508
|
|
G |
Rps20 |
ribosomal protein S20 |
affects expression |
EXP |
Omeprazole affects the expression of RPS20 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 5:16,819,304...16,820,475 Ensembl chr 9:16,819,304...16,820,475 Ensembl chr 3:16,819,304...16,820,475 Ensembl chr 5:16,819,304...16,820,475
|
|
G |
Rps3a |
ribosomal protein S3a |
affects expression |
EXP |
Omeprazole affects the expression of RPS3A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:171,524,685...171,529,054
Ensembl chr 2:171,524,500...171,529,055
|
|
G |
Rps6 |
ribosomal protein S6 |
affects expression |
EXP |
Omeprazole affects the expression of RPS6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps8 |
ribosomal protein S8 |
affects expression |
EXP |
Omeprazole affects the expression of RPS8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:130,630,362...130,632,932
Ensembl chr 5:130,629,716...130,633,268
|
|
G |
Rras2 |
RAS related 2 |
affects expression |
EXP |
Omeprazole affects the expression of RRAS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
|
|
G |
RT1-DMa |
RT1 class II, locus DMa |
affects expression |
ISO |
Omeprazole affects the expression of HLA-DMA mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
affects expression |
ISO |
Omeprazole affects the expression of HLA-G mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
RT1-S3 |
RT1 class Ib, locus S3 |
affects expression |
EXP |
Omeprazole affects the expression of RT1-S3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:2,670,654...2,675,411
Ensembl chr20:2,670,709...2,675,411
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
affects expression |
EXP |
Omeprazole affects the expression of S1PR1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
affects expression |
EXP |
Omeprazole affects the expression of SBSPON mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:3,402,763...3,433,338
Ensembl chr 5:3,402,648...3,435,420
|
|
G |
Sdc2 |
syndecan 2 |
affects expression |
EXP |
Omeprazole affects the expression of SDC2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sdhc |
succinate dehydrogenase complex subunit C |
affects expression |
EXP |
Omeprazole affects the expression of SDHC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:83,544,652...83,565,560
Ensembl chr13:83,544,652...83,566,253
|
|
G |
Sdhd |
succinate dehydrogenase complex subunit D |
affects expression |
EXP |
Omeprazole affects the expression of SDHD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:50,944,702...50,954,298
Ensembl chr 8:50,944,704...50,954,238
|
|
G |
Sell |
selectin L |
decreases expression |
EXP |
Omeprazole results in decreased expression of SELL protein |
CTD |
PMID:17652263 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Serinc3 |
serine incorporator 3 |
affects expression |
EXP |
Omeprazole affects the expression of SERINC3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
|
|
G |
Serpina1 |
serpin family A member 1 |
affects expression |
EXP |
Omeprazole affects the expression of SERPINA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpina10 |
serpin family A member 10 |
affects expression |
EXP |
Omeprazole affects the expression of SERPINA10 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:122,756,106...122,764,544
Ensembl chr 6:122,756,108...122,764,544
|
|
G |
Serpina4 |
serpin family A member 4 |
affects expression |
EXP |
Omeprazole affects the expression of SERPINA4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:122,999,970...123,009,083
Ensembl chr 6:122,999,900...123,009,082
|
|
G |
Serpinf2 |
serpin family F member 2 |
affects expression |
EXP |
Omeprazole affects the expression of SERPINF2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243
|
|
G |
Serping1 |
serpin family G member 1 |
decreases expression |
EXP |
Omeprazole results in decreased expression of SERPING1 mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sfxn1 |
sideroflexin 1 |
affects expression |
EXP |
Omeprazole affects the expression of SFXN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 |
affects expression |
EXP |
Omeprazole affects the expression of SHMT2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
affects expression |
EXP |
Omeprazole affects the expression of SLC22A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
multiple interactions |
EXP |
Dithioerythritol inhibits the reaction [Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]]; Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine] |
CTD |
PMID:19041296 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
ISO |
[Omeprazole results in decreased activity of SLC22A8 protein] which results in decreased uptake of Indican |
CTD |
PMID:36243147 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc23a1 |
solute carrier family 23 member 1 |
affects expression |
EXP |
Omeprazole affects the expression of SLC23A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
|
|
G |
Slc25a13 |
solute carrier family 25 member 13 |
affects expression |
EXP |
Omeprazole affects the expression of SLC25A13 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902
|
|
G |
Slc25a3 |
solute carrier family 25 member 3 |
affects expression |
EXP |
Omeprazole affects the expression of SLC25A3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
affects expression |
EXP |
Omeprazole affects the expression of SLC27A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc39a8 |
solute carrier family 39 member 8 |
affects expression |
EXP |
Omeprazole affects the expression of SLC39A8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
decreases expression |
ISO |
Omeprazole results in decreased expression of SLC40A1 protein |
CTD |
PMID:31669099 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc46a1 |
solute carrier family 46 member 1 |
affects expression |
EXP |
Omeprazole affects the expression of SLC46A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
|
|
G |
Slc66a2 |
solute carrier family 66 member 2 |
affects expression |
EXP |
Omeprazole affects the expression of SLC66A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:73,702,472...73,739,678
Ensembl chr18:73,702,564...73,739,676
|
|
G |
Slc6a6 |
solute carrier family 6 member 6 |
affects expression |
EXP |
Omeprazole affects the expression of SLC6A6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
increases expression |
ISO |
Omeprazole results in increased expression of SLCO1A2 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Ethanol results in decreased activity of SOD1 protein] |
CTD |
PMID:28849987 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sppl2a |
signal peptide peptidase-like 2A |
affects expression |
EXP |
Omeprazole affects the expression of SPPL2A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:114,149,337...114,193,408
Ensembl chr 3:114,151,069...114,193,264
|
|
G |
Srm |
spermidine synthase |
affects expression |
EXP |
Omeprazole affects the expression of SRM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srprb |
SRP receptor subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of SRPRB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:103,768,685...103,782,632
|
|
G |
Ssx2ip |
SSX family member 2 interacting protein |
affects expression |
EXP |
Omeprazole affects the expression of SSX2IP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
|
|
G |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
affects expression |
EXP |
Omeprazole affects the expression of ST3GAL6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ST6GAL1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
|
|
G |
Suclg1 |
succinate-CoA ligase GDP/ADP-forming subunit alpha |
affects expression |
EXP |
Omeprazole affects the expression of SUCLG1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
|
|
G |
Surf4 |
surfeit 4 |
affects expression |
EXP |
Omeprazole affects the expression of SURF4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:10,248,360...10,261,537
Ensembl chr 3:10,241,837...10,263,315
|
|
G |
Synj2bp |
synaptojanin 2 binding protein |
affects expression |
EXP |
Omeprazole affects the expression of SYNJ2BP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406
|
|
G |
Tacr1 |
tachykinin receptor 1 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Acids affects the localization of TACR1 protein] |
CTD |
PMID:16091555 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
Omeprazole results in increased expression of TGFB1 protein |
CTD |
PMID:36243147 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
affects expression |
EXP |
Omeprazole affects the expression of TGFBI mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Thnsl2 |
threonine synthase-like 2 |
affects expression |
EXP |
Omeprazole affects the expression of THNSL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:103,112,974...103,132,122
Ensembl chr 4:103,112,963...103,132,017
|
|
G |
Timm21 |
translocase of inner mitochondrial membrane 21 |
affects expression |
EXP |
Omeprazole affects the expression of TIMM21 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:78,314,900...78,319,362
Ensembl chr18:78,314,909...78,319,454
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Indomethacin results in increased expression of TIMP2 protein] |
CTD |
PMID:16934674 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tkfc |
triokinase and FMN cyclase |
affects expression |
EXP |
Omeprazole affects the expression of TKFC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased expression of TLR4 protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased expression of TLR4 protein] |
CTD |
PMID:32418911 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
affects expression |
EXP |
Omeprazole affects the expression of TMBIM1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:75,871,835...75,889,366
Ensembl chr 9:75,871,835...75,889,069
|
|
G |
Tmco1 |
transmembrane and coiled-coil domains 1 |
affects expression |
EXP |
Omeprazole affects the expression of TMCO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:79,460,229...79,483,557
Ensembl chr13:79,460,135...79,483,555
|
|
G |
Tmed2 |
transmembrane p24 trafficking protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of TMED2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:32,052,542...32,061,628
Ensembl chr12:32,052,543...32,071,903
|
|
G |
Tmed7 |
transmembrane p24 trafficking protein 7 |
affects expression |
EXP |
Omeprazole affects the expression of TMED7 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:39,318,564...39,325,640
Ensembl chr18:39,297,351...39,325,640
|
|
G |
Tmem123 |
transmembrane protein 123 |
affects expression |
EXP |
Omeprazole affects the expression of TMEM123 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:4,922,077...4,952,228
Ensembl chr 8:4,922,098...4,952,224
|
|
G |
Tmem97 |
transmembrane protein 97 |
affects expression |
EXP |
Omeprazole affects the expression of TMEM97 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Tmprss2 |
transmembrane serine protease 2 |
increases expression |
EXP |
Omeprazole results in increased expression of TMPRSS2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Omeprazole inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] Omeprazole inhibits the reaction [Ethanol results in increased expression of TNF protein] Omeprazole inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Omeprazole inhibits the reaction [Ethanol results in decreased expression of TNF protein] |
CTD |
PMID:19232345 PMID:25637687 PMID:26970604 PMID:30452898 PMID:32418911 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Txn1 |
thioredoxin 1 |
affects expression |
EXP |
Omeprazole affects the expression of TXN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnl1 |
thioredoxin-like 1 |
affects expression |
EXP |
Omeprazole affects the expression of TXNL1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
|
|
G |
Tyr |
tyrosinase |
multiple interactions decreases expression |
ISO |
Omeprazole affects the N-linked glycosylation of and results in increased degradation of TYR protein; Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein] Omeprazole results in decreased expression of TYR protein |
CTD |
PMID:25337692 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
affects expression |
EXP |
Omeprazole affects the expression of UBA52 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
|
|
G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
affects expression |
EXP |
Omeprazole affects the expression of UBE2N mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
|
|
G |
Ufd1 |
ubiquitin recognition factor in ER associated degradation 1 |
affects expression |
EXP |
Omeprazole affects the expression of UFD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:82,161,618...82,185,107
Ensembl chr11:82,161,619...82,185,087
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression affects expression |
ISO EXP |
Omeprazole results in increased expression of UGT1A1 mRNA Omeprazole affects the expression of UGT1A1 mRNA |
CTD |
PMID:19118567 PMID:19483382 PMID:25626140 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases expression |
ISO |
Omeprazole results in increased expression of UGT1A2 mRNA; Omeprazole results in increased expression of UGT1A3 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a3 |
UDP glycosyltransferase 1 family, polypeptide A3 |
increases expression |
ISO |
Omeprazole results in increased expression of UGT1A5 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 9:88,780,328...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases expression |
ISO |
Omeprazole results in increased expression of UGT1A4 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions increases expression |
EXP ISO |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA Omeprazole results in increased expression of UGT1A6 mRNA |
CTD |
PMID:19118567 PMID:22687989 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases expression |
ISO |
Omeprazole results in increased expression of UGT1A9 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases expression |
EXP |
Omeprazole results in increased expression of UGT2B1 mRNA |
CTD |
PMID:25626140 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
affects expression |
EXP |
Omeprazole affects the expression of UQCR11 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Vnn1 |
vanin 1 |
affects expression |
EXP |
Omeprazole affects the expression of VNN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Wdr26 |
WD repeat domain 26 |
affects expression |
EXP |
Omeprazole affects the expression of WDR26 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
|
|
G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
affects expression |
EXP |
Omeprazole affects the expression of YWHAG mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
|
|
G |
Zdhhc23 |
zinc finger DHHC-type palmitoyltransferase 23 |
affects expression |
EXP |
Omeprazole affects the expression of ZDHHC23 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:56,718,702...56,735,063
Ensembl chr11:56,718,826...56,734,194
|
|
G |
Zwint |
ZW10 interacting kinetochore protein |
affects expression |
EXP |
Omeprazole affects the expression of ZWINT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
5-hydroxymethylomeprazole results in increased expression of CYP1A1 protein |
CTD |
PMID:10103034 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
Mycophenolic Acid promotes the reaction [Esomeprazole results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:25929522 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
Omeprazole results in increased expression of ABCA1 mRNA |
CTD |
PMID:20060385 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Omeprazole results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects expression multiple interactions |
EXP ISO |
Omeprazole affects the expression of ABCB1A mRNA Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1A protein] Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1 protein] |
CTD |
PMID:19483382 PMID:30452898 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
Omeprazole results in decreased expression of ABCB4 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Omeprazole results in increased susceptibility to Cisplatin] which results in decreased expression of ABCC2 protein |
CTD |
PMID:35447140 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
Omeprazole results in increased expression of ABCC3 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
affects expression |
EXP |
Omeprazole affects the expression of ABCC6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression multiple interactions |
ISO |
Omeprazole results in increased expression of ABCG2 mRNA alternative form; Omeprazole results in increased expression of ABCG2 protein Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow] |
CTD |
PMID:20804740 PMID:31348918 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
affects expression |
EXP |
Omeprazole affects the expression of ABCG5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
affects expression |
EXP |
Omeprazole affects the expression of ABHD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
affects expression |
EXP |
Omeprazole affects the expression of ABHD14B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Abhd17a |
abhydrolase domain containing 17A, depalmitoylase |
affects expression |
EXP |
Omeprazole affects the expression of ABHD17A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
affects expression |
EXP |
Omeprazole affects the expression of ACACA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
affects expression |
EXP |
Omeprazole affects the expression of ACADL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
decreases expression |
EXP ISO |
Omeprazole results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Aco1 |
aconitase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ACO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Aco2 |
aconitase 2 |
affects expression |
EXP |
Omeprazole affects the expression of ACO2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
affects expression |
EXP |
Omeprazole affects the expression of ACOT12 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
affects expression |
EXP |
Omeprazole affects the expression of ACOT4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
affects expression |
EXP |
Omeprazole affects the expression of ADAM15 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Add1 |
adducin 1 |
affects expression |
EXP |
Omeprazole affects the expression of ADD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
ISO |
Omeprazole results in decreased expression of ADH1C mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
affects expression |
EXP |
Omeprazole affects the expression of ADH4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
affects expression |
EXP |
Omeprazole affects the expression of ADTRP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Afm |
afamin |
affects expression |
EXP |
Omeprazole affects the expression of AFM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Agt |
angiotensinogen |
affects expression |
EXP |
Omeprazole affects the expression of AGT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
affects expression |
EXP |
Omeprazole affects the expression of AGTR1A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases response to substance affects localization decreases expression increases expression increases activity decreases activity |
ISO EXP |
AG-879 inhibits the reaction [Omeprazole results in increased activity of AHR protein]; AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of AHR mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein]; Omeprazole binds to and results in increased activity of AHR protein; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; omeprazole sulfide inhibits the reaction [Omeprazole results in increased activity of AHR protein]; Puromycin inhibits the reaction [Omeprazole results in increased expression of AHR protein] [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] AHR protein results in increased susceptibility to Omeprazole Omeprazole affects the localization of AHR protein Omeprazole results in decreased activity of AHR protein |
CTD |
PMID:9139728 PMID:9395520 PMID:14742684 PMID:16109480 PMID:20171196 PMID:21703235 PMID:21861773 PMID:21924250 PMID:22687989 PMID:23850985 PMID:25797602 PMID:25826687 PMID:26187274 PMID:26272953 PMID:31669099 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
affects expression |
EXP |
Omeprazole affects the expression of AKR1A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
affects expression |
EXP |
Omeprazole affects the expression of AKR7A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of AKR7A3 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of ALDH1A1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
Omeprazole results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects expression |
EXP |
Omeprazole affects the expression of ALDH2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
Omeprazole results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:12040753 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alkbh7 |
alkB homolog 7 |
affects expression |
EXP |
Omeprazole affects the expression of ALKBH7 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:1,838,886...1,841,044
Ensembl chr 9:1,838,811...1,841,044
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
affects expression |
EXP |
Omeprazole affects the expression of AP2M1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Apcs |
amyloid P component, serum |
affects expression |
EXP |
Omeprazole affects the expression of APCS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
Omeprazole affects the expression of APOA4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoh |
apolipoprotein H |
affects expression |
EXP |
Omeprazole affects the expression of APOH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apool |
apolipoprotein O-like |
affects expression |
EXP |
Omeprazole affects the expression of APOOL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:77,377,723...77,443,672
Ensembl chr X:77,377,781...77,443,900
|
|
G |
Arg1 |
arginase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ARG1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arl6ip1 |
ARL6 interacting reticulophagy regulator 1 |
affects expression |
EXP |
Omeprazole affects the expression of ARL6IP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions affects localization |
ISO EXP |
Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter] Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] Omeprazole affects the localization of ARNT protein |
CTD |
PMID:9395520 PMID:21703235 PMID:25826687 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
affects expression |
EXP |
Omeprazole affects the expression of ASGR2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Atf5 |
activating transcription factor 5 |
affects expression |
EXP |
Omeprazole affects the expression of ATF5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
affects expression |
EXP |
Omeprazole affects the expression of ATP5F1E mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of ATP6AP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:10,183,983...10,210,948
Ensembl chr X:10,183,068...10,210,918
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
affects expression |
EXP |
Omeprazole affects the expression of ATP6V1A mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atp6v1f |
ATPase H+ transporting V1 subunit F |
affects expression |
EXP |
Omeprazole affects the expression of ATP6V1F mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:58,067,666...58,070,628
|
|
G |
Atp7a |
ATPase copper transporting alpha |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein] Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein] |
CTD |
PMID:25337692 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of BAAT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of BAX protein] |
CTD |
PMID:30452898 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] |
CTD |
PMID:30452898 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
affects expression |
EXP |
Omeprazole affects the expression of BCL6B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bltp3b |
bridge-like lipid transfer protein family member 3B |
affects expression |
EXP |
Omeprazole affects the expression of BLTP3B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
|
|
G |
Bmf |
Bcl2 modifying factor |
affects expression |
EXP |
Omeprazole affects the expression of BMF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmx |
BMX non-receptor tyrosine kinase |
multiple interactions |
ISO |
BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein] |
CTD |
PMID:21861773 |
|
NCBI chr X:30,227,251...30,290,015
Ensembl chr X:30,227,251...30,289,993
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
affects expression |
EXP |
Omeprazole affects the expression of BNIP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Btf3 |
basic transcription factor 3 |
affects expression |
EXP |
Omeprazole affects the expression of BTF3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
Omeprazole results in decreased expression of C1QA mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qbp |
complement C1q binding protein |
affects expression |
EXP |
Omeprazole affects the expression of C1QBP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
Omeprazole results in decreased expression of C1QC mRNA |
CTD |
PMID:25626140 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1s |
complement C1s |
affects expression |
EXP |
Omeprazole affects the expression of C1S mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
affects expression |
EXP |
Omeprazole affects the expression of C2CD2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
affects expression decreases expression |
EXP |
Omeprazole affects the expression of C4BPA mRNA Omeprazole results in decreased expression of C4BPA mRNA |
CTD |
PMID:19483382 PMID:25626140 |
|
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
decreases expression |
EXP |
Omeprazole results in decreased expression of C4BPB mRNA |
CTD |
PMID:25626140 |
|
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C7 |
complement C7 |
affects expression |
EXP |
Omeprazole affects the expression of C7 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8b |
complement C8 beta chain |
affects expression |
EXP |
Omeprazole affects the expression of C8B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:119,535,009...119,572,565
Ensembl chr 5:119,535,146...119,572,565
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
affects expression |
EXP |
Omeprazole affects the expression of CADPS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:51,780,415...52,309,641
Ensembl chr 4:51,781,053...52,309,829
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CAPRIN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Car2 |
carbonic anhydrase 2 |
affects expression |
EXP |
Omeprazole affects the expression of CA2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car3 |
carbonic anhydrase 3 |
affects expression |
EXP |
Omeprazole affects the expression of CAR3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casp3 |
caspase 3 |
increases activity increases cleavage affects expression multiple interactions |
ISO EXP |
Omeprazole analog results in increased activity of CASP3 protein; Omeprazole results in increased activity of CASP3 protein Omeprazole results in increased cleavage of CASP3 protein Omeprazole affects the expression of CASP3 mRNA Omeprazole inhibits the reaction [Ethanol results in increased activity of CASP3 protein]; Omeprazole inhibits the reaction [Ethanol results in increased expression of CASP3 mRNA]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of CASP3 protein] Omeprazole inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] |
CTD |
PMID:15461867 PMID:18336733 PMID:19251492 PMID:19483382 PMID:25637687 PMID:30452898 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
Omeprazole analog results in increased cleavage of CASP8 protein |
CTD |
PMID:18336733 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP ISO |
Omeprazole results in increased activity of CAT protein Omeprazole inhibits the reaction [Acetic Acid results in increased activity of CAT protein] Omeprazole inhibits the reaction [Ethanol results in decreased activity of CAT protein] |
CTD |
PMID:18547560 PMID:28849987 PMID:33245926 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CBR1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cckbr |
cholecystokinin B receptor |
multiple interactions |
ISO |
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3 |
CTD |
PMID:17704804 |
|
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
Omeprazole results in decreased expression of CCND1 mRNA |
CTD |
PMID:17202759 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Omeprazole results in increased expression of CDKN1A protein |
CTD |
PMID:27358234 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
affects expression |
EXP |
Omeprazole affects the expression of CDO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CEPT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578
|
|
G |
Ces2h |
carboxylesterase 2H |
affects expression |
EXP |
Omeprazole affects the expression of CES2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfi |
complement factor I |
affects expression decreases expression |
EXP |
Omeprazole affects the expression of CFI mRNA Omeprazole results in decreased expression of CFI mRNA |
CTD |
PMID:19483382 PMID:25626140 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cftr |
CF transmembrane conductance regulator |
affects metabolic processing |
ISO |
CFTR protein affects the metabolism of Omeprazole |
CTD |
PMID:15319328 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CHP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
affects expression |
EXP |
Omeprazole affects the expression of CISD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
affects expression |
EXP |
Omeprazole affects the expression of CLCN4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
affects expression |
EXP |
Omeprazole affects the expression of CLPP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
|
|
G |
Clptm1l |
CLPTM1-like |
affects expression |
EXP |
Omeprazole affects the expression of CLPTM1L mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
affects expression |
EXP |
Omeprazole affects the expression of CMBL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
affects expression |
EXP |
Omeprazole affects the expression of CMPK1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
affects expression |
EXP |
Omeprazole affects the expression of COPG1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Cops4 |
COP9 signalosome subunit 4 |
affects expression |
EXP |
Omeprazole affects the expression of COPS4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of COQ3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
affects expression |
EXP |
Omeprazole affects the expression of COX4I1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpn1 |
carboxypeptidase N subunit 1 |
affects expression |
EXP |
Omeprazole affects the expression of CPN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
|
|
G |
Cpq |
carboxypeptidase Q |
affects expression |
EXP |
Omeprazole affects the expression of CPQ mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Crem |
cAMP responsive element modulator |
affects expression |
EXP |
Omeprazole affects the expression of CREM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Csnk2b |
casein kinase 2 beta |
affects expression |
EXP |
Omeprazole affects the expression of CSNK2B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of CSRP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctnna1 |
catenin alpha 1 |
affects expression |
EXP |
Omeprazole affects the expression of CTNNA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctsb |
cathepsin B |
decreases activity |
ISO |
Omeprazole results in decreased activity of CTSB protein |
CTD |
PMID:34871754 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein] |
CTD |
PMID:20165931 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctse |
cathepsin E |
decreases expression |
EXP |
Omeprazole results in decreased expression of CTSE |
CTD |
PMID:7575556 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression multiple interactions |
ISO |
Omeprazole results in decreased expression of CXCR4 mRNA AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA] |
CTD |
PMID:25826687 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity multiple interactions increases expression decreases activity |
ISO EXP |
Omeprazole results in increased activity of CYP1A1 promoter Omeprazole results in increased activity of CYP1A1 protein AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter] Omeprazole results in increased expression of CYP1A1 mRNA; Omeprazole results in increased expression of CYP1A1 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; lavendustin A inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Staurosporine inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Tosyllysine Chloromethyl Ketone inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA] Omeprazole results in decreased activity of CYP1A1 protein Omeprazole inhibits the reaction [Oxygen results in increased expression of CYP1A1 protein]; Omeprazole promotes the reaction [Oxygen results in decreased expression of CYP1A1 mRNA] |
CTD |
PMID:8647108 PMID:8900397 PMID:9041675 PMID:9139728 PMID:9152597 PMID:9395520 PMID:9860486 PMID:10103034 PMID:10859152 PMID:11454723 PMID:11849738 PMID:12040753 PMID:12623754 PMID:12841937 PMID:14742684 PMID:14987951 PMID:15681896 PMID:15860653 PMID:17202759 PMID:17954527 PMID:18420780 PMID:18502397 PMID:19118567 PMID:20171196 PMID:21666223 PMID:21703235 PMID:21784029 PMID:22687989 PMID:25626140 PMID:25826687 PMID:26187180 PMID:26272953 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity decreases activity multiple interactions increases expression |
ISO EXP |
Omeprazole results in increased activity of CYP1A2 promoter; Omeprazole results in increased activity of CYP1A2 protein Omeprazole results in decreased activity of CYP1A2 protein [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA |
CTD |
PMID:9152597 PMID:9744552 PMID:12040753 PMID:12623754 PMID:12841937 PMID:15681896 PMID:15802389 PMID:16035375 PMID:17954527 PMID:18332078 PMID:18420780 PMID:18502397 PMID:19118567 PMID:19230594 PMID:20171196 PMID:21784029 PMID:21924250 PMID:22524704 PMID:22687989 PMID:23274770 PMID:23850985 PMID:24752503 PMID:25626140 PMID:26204831 PMID:27794450 PMID:30044681 PMID:31863871 PMID:36288780 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions increases expression decreases activity affects expression |
ISO |
Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter] Omeprazole results in increased expression of CYP1B1 mRNA Omeprazole results in decreased activity of CYP1B1 protein Omeprazole affects the expression of CYP1B1 mRNA |
CTD |
PMID:12040753 PMID:12623754 PMID:18420780 PMID:21703235 PMID:25826687 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2A1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Omeprazole results in increased expression of CYP2B1 mRNA; Omeprazole results in increased expression of CYP2B1 protein |
CTD |
PMID:9152597 PMID:19118567 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression affects expression |
EXP |
Omeprazole results in increased expression of CYP2B2 protein Omeprazole affects the expression of CYP2B2 mRNA |
CTD |
PMID:9152597 PMID:19483382 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects expression increases activity increases expression decreases activity |
EXP ISO |
Omeprazole affects the expression of CYP2B3 mRNA Omeprazole results in increased activity of CYP2B6 protein Omeprazole results in increased expression of CYP2B6 mRNA Omeprazole results in decreased activity of CYP2B10 protein |
CTD |
PMID:17954527 PMID:18420780 PMID:19118567 PMID:19483382 PMID:22524704 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases metabolic processing affects metabolic processing increases metabolic processing increases hydroxylation multiple interactions decreases activity |
ISO |
CYP2C19 gene alternative form results in decreased metabolism of Omeprazole CYP2C19 protein affects the metabolism of Omeprazole CYP2C19 protein results in increased metabolism of Omeprazole CYP2C19 protein results in increased hydroxylation of Omeprazole [5-bromotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-chlorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [7-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Chloramphenicol results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Fluconazole results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [indopan results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of Aconitine metabolite; [Tryptamines analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; Omeprazole affects the reaction [CYP2C19 protein affects the metabolism of Warfarin]; Omeprazole inhibits the reaction [CYP2C19 protein results in decreased methylation of adinazolam]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased chemical synthesis of 4-hydroxymephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased hydroxylation of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of auriculasin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Fluoxetine]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of 2-oxo-clopidogrel]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of Clopidogrel] |
CTD |
PMID:8930576 PMID:9600717 PMID:11752104 PMID:12464242 PMID:12467917 PMID:12485723 PMID:12637241 PMID:14586384 PMID:15258107 PMID:15286053 PMID:15306208 PMID:15626586 PMID:16035375 PMID:17565714 PMID:17702393 PMID:18511451 PMID:18520598 PMID:19812348 PMID:20573087 PMID:21277363 PMID:21795468 PMID:21915887 PMID:22634058 PMID:26599973 PMID:31515991 More...
|
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2D3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
affects expression decreases activity |
EXP ISO |
Omeprazole affects the expression of CYP2D4 mRNA Omeprazole results in decreased activity of CYP2D6 protein |
CTD |
PMID:18420780 PMID:19483382 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
Omeprazole results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:15802389 PMID:36243147 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2F4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2J4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
affects expression |
EXP |
Omeprazole affects the expression of CYP2T1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
affects metabolic processing increases expression multiple interactions increases metabolic processing |
ISO |
CYP3A4 protein affects the metabolism of Omeprazole Omeprazole results in increased expression of CYP3A4 mRNA; Omeprazole results in increased expression of CYP3A4 protein [Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; NR1I2 protein affects the reaction [Omeprazole results in increased expression of CYP3A4 mRNA]; Omeprazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Omeprazole results in increased expression of and results in increased activity of CYP3A4 protein CYP3A4 protein results in increased metabolism of Omeprazole |
CTD |
PMID:7870052 PMID:8930576 PMID:9744552 PMID:12235278 PMID:12485723 PMID:12695340 PMID:15286053 PMID:15466163 PMID:15626586 PMID:15802389 PMID:17041008 PMID:17565714 PMID:17954527 PMID:19118567 PMID:19299527 PMID:22634058 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
affects expression increases expression |
EXP |
Omeprazole affects the expression of CYP3A23-3A1 mRNA Omeprazole results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:19118567 PMID:19483382 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects expression increases expression |
EXP ISO |
Omeprazole affects the expression of CYP3A9 mRNA Omeprazole results in increased expression of CYP3A5 mRNA |
CTD |
PMID:19118567 PMID:19483382 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
affects expression |
EXP |
Omeprazole affects the expression of CYP4A8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
affects expression |
EXP |
Omeprazole affects the expression of CYP4F6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Dbi |
diazepam binding inhibitor |
affects expression |
EXP |
Omeprazole affects the expression of DBI mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
affects expression |
EXP |
Omeprazole affects the expression of DCAF11 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
affects expression |
EXP |
Omeprazole affects the expression of DCXR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Omeprazole results in increased expression of DDIT3 protein |
CTD |
PMID:27358234 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
affects expression |
EXP |
Omeprazole affects the expression of DECR1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dexi |
Dexi homolog |
affects expression |
EXP |
Omeprazole affects the expression of DEXI mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of DGAT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
affects expression |
EXP |
Omeprazole affects the expression of DHCR24 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
affects expression |
EXP |
Omeprazole affects the expression of DHRS4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
affects expression |
EXP |
Omeprazole affects the expression of DHRS7B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhx16 |
DEAH-box helicase 16 |
affects expression |
EXP |
Omeprazole affects the expression of DHX16 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:2,862,000...2,874,991
Ensembl chr20:2,862,000...2,874,948
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
affects expression |
EXP |
Omeprazole affects the expression of DMAC2L mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
affects expression |
EXP |
Omeprazole affects the expression of DNAJC3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
affects expression |
EXP |
Omeprazole affects the expression of DPP4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of DPYD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Ears2 |
glutamyl-tRNA synthetase 2, mitochondrial |
affects expression |
EXP |
Omeprazole affects the expression of EARS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:176,597,986...176,625,848
Ensembl chr 1:176,597,986...176,625,836
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
affects expression |
EXP |
Omeprazole affects the expression of ECHS1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ECI1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
affects expression |
EXP |
Omeprazole affects the expression of ECI2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
affects expression |
EXP |
Omeprazole affects the expression of EEF1G mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Omeprazole promotes the reaction [Indomethacin results in increased expression of EGF protein] |
CTD |
PMID:18431645 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of EHHADH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
affects expression |
EXP |
Omeprazole affects the expression of EIF4A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of EIF4EBP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4h |
eukaryotic translation initiation factor 4H |
affects expression |
EXP |
Omeprazole affects the expression of EIF4H mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENC1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Eno1 |
enolase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Enpep |
glutamyl aminopeptidase |
affects expression |
EXP |
Omeprazole affects the expression of ENPEP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ENPP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter] |
CTD |
PMID:21703235 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epcam |
epithelial cell adhesion molecule |
affects expression |
EXP |
Omeprazole affects the expression of EPCAM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
affects expression |
EXP |
Omeprazole affects the expression of ERP29 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Esd |
esterase D |
affects expression |
EXP |
Omeprazole affects the expression of ESD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of ETFB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
|
|
G |
Faah |
fatty acid amide hydrolase |
affects expression |
EXP |
Omeprazole affects the expression of FAAH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fads2 |
fatty acid desaturase 2 |
affects expression |
EXP |
Omeprazole affects the expression of FADS2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FBP1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FDFT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
affects expression |
EXP |
Omeprazole affects the expression of FDPS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fdx2 |
ferredoxin 2 |
affects expression |
EXP |
Omeprazole affects the expression of FDX2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:19,604,916...19,609,832
Ensembl chr 8:19,604,916...19,609,849
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
affects expression |
EXP |
Omeprazole affects the expression of FMO1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of GAMT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of GAPDH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gast |
gastrin |
increases expression |
ISO EXP |
Omeprazole results in increased expression of GAST protein |
CTD |
PMID:11422300 PMID:12189558 PMID:12763636 PMID:15223672 PMID:16618411 PMID:17652263 More...
|
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
affects expression |
EXP |
Omeprazole affects the expression of GBE1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
affects expression |
EXP |
Omeprazole affects the expression of GCHFR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
affects expression |
EXP |
Omeprazole affects the expression of GGH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GGT1 mRNA |
CTD |
PMID:22687989 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
affects expression |
EXP |
Omeprazole affects the expression of GJB1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
affects expression |
EXP |
Omeprazole affects the expression of GPLD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects expression |
EXP |
Omeprazole affects the expression of GPX1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA |
CTD |
PMID:22687989 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
affects expression |
EXP |
Omeprazole affects the expression of GPX4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
affects expression |
EXP |
Omeprazole affects the expression of GRINA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
affects expression |
EXP |
Omeprazole affects the expression of GRPEL1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression multiple interactions |
EXP |
Omeprazole results in increased expression of GSTA5 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA |
CTD |
PMID:17202759 PMID:22687989 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Omeprazole results in increased expression of GSTP1 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
affects expression |
EXP |
Omeprazole affects the expression of GSTT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
affects expression |
EXP |
Omeprazole affects the expression of GTF2H5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gzma |
granzyme A |
affects expression |
EXP |
Omeprazole affects the expression of GZMA mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
H3f3b |
H3.3 histone B |
affects expression |
EXP |
Omeprazole affects the expression of H3F3B mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709 Ensembl chr13:101,256,480...101,258,709
|
|
G |
Hal |
histidine ammonia lyase |
affects expression |
EXP |
Omeprazole affects the expression of HAL mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
increases expression increases secretion multiple interactions |
ISO |
Omeprazole results in increased expression of HAMP mRNA Omeprazole results in increased secretion of HAMP protein Omeprazole results in increased expression of HAMP mRNA; Omeprazole results in increased expression of HAMP protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA] |
CTD |
PMID:31669099 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
affects expression |
EXP |
Omeprazole affects the expression of HAO2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
affects expression |
EXP |
Omeprazole affects the expression of HBA-A2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbb |
hemoglobin subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of HBB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hdc |
histidine decarboxylase |
affects expression multiple interactions increases expression increases stability |
EXP |
Omeprazole affects the expression of HDC mRNA Omeprazole results in increased expression of and results in increased activity of HDC protein Omeprazole results in increased expression of HDC mRNA Omeprazole results in increased stability of HDC protein |
CTD |
PMID:12763636 PMID:19483382 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
affects expression |
EXP |
Omeprazole affects the expression of HGD mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
|
|
G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
affects expression |
EXP |
Omeprazole affects the expression of HMGN1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:35,422,328...35,428,247
Ensembl chr11:35,422,328...35,428,254
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein]; Omeprazole results in increased expression of and results in increased activity of HMOX1 protein Omeprazole results in increased expression of HMOX1 mRNA; Omeprazole results in increased expression of HMOX1 protein |
CTD |
PMID:16712795 PMID:27725188 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of HPRT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hps5 |
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2 |
affects expression |
EXP |
Omeprazole affects the expression of HPS5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:97,281,626...97,320,945
Ensembl chr 1:97,247,598...97,321,019
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
affects expression |
EXP |
Omeprazole affects the expression of HSD17B4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
affects expression |
EXP |
Omeprazole affects the expression of HSDL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression multiple interactions |
EXP |
Omeprazole results in decreased expression of HSPA1A mRNA; Omeprazole results in decreased expression of HSPA1A protein Zinc Compounds analog inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein]; Zinc Sulfate inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein] |
CTD |
PMID:15223672 PMID:16945336 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] |
CTD |
PMID:25637687 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
affects expression |
EXP |
Omeprazole affects the expression of HTRA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
ISO |
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3 |
CTD |
PMID:17704804 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] |
CTD |
PMID:19232345 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
EXP |
Omeprazole affects the expression of IGF1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
affects expression |
EXP |
Omeprazole affects the expression of IGFALS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of IGFBP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL10 protein] |
CTD |
PMID:26970604 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL1B protein] |
CTD |
PMID:32418911 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL6 protein]; Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL6 protein] |
CTD |
PMID:25637687 PMID:32418911 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Impa1 |
inositol monophosphatase 1 |
affects expression |
EXP |
Omeprazole affects the expression of IMPA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
|
|
G |
Inhbe |
inhibin subunit beta E |
affects expression |
EXP |
Omeprazole affects the expression of INHBE mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
affects expression |
EXP |
Omeprazole affects the expression of ISYNA1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
affects expression |
EXP |
Omeprazole affects the expression of ITIH4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jak1 |
Janus kinase 1 |
affects expression |
EXP |
Omeprazole affects the expression of JAK1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Kdelr2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
affects expression |
EXP |
Omeprazole affects the expression of KDELR2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
|
|
G |
Kdr |
kinase insert domain receptor |
affects expression multiple interactions |
EXP ISO |
Omeprazole affects the expression of KDR mRNA Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein] |
CTD |
PMID:19483382 PMID:26272953 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Krt8 |
keratin 8 |
affects expression |
EXP |
Omeprazole affects the expression of KRT8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
affects expression |
EXP |
Omeprazole affects the expression of LCAT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
affects expression |
EXP |
Omeprazole affects the expression of LCMT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
|
|
G |
Lipc |
lipase C, hepatic type |
affects expression |
EXP |
Omeprazole affects the expression of LIPC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lox |
lysyl oxidase |
affects expression |
EXP |
Omeprazole affects the expression of LOX mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrp3 |
LDL receptor related protein 3 |
affects expression |
EXP |
Omeprazole affects the expression of LRP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:87,843,815...87,859,147
Ensembl chr 1:87,844,868...87,859,110
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
affects expression |
EXP |
Omeprazole affects the expression of MAN2B1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
affects expression |
EXP |
Omeprazole affects the expression of MAP2K2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:17406807 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Masp2 |
MBL associated serine protease 2 |
affects expression |
EXP |
Omeprazole affects the expression of MASP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
|
|
G |
Me1 |
malic enzyme 1 |
affects expression multiple interactions |
EXP |
Omeprazole affects the expression of ME1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA |
CTD |
PMID:19483382 PMID:22687989 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Indomethacin results in decreased expression of MMP14 protein] |
CTD |
PMID:16934674 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Hydrogen Peroxide results in decreased activity of MMP2 protein] |
CTD |
PMID:16934674 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
affects expression |
EXP |
Omeprazole affects the expression of MMUT mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions decreases activity |
ISO EXP |
Omeprazole inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Acids results in increased activity of MPO protein] Omeprazole inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Cysteamine results in increased expression of MPO protein]; Omeprazole inhibits the reaction [Ethanol results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of MPO protein] Omeprazole results in decreased activity of MPO protein |
CTD |
PMID:16091555 PMID:17151854 PMID:20165931 PMID:25637687 PMID:27780710 PMID:29770154 PMID:31095933 PMID:33245926 More...
|
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mro |
maestro |
affects expression |
EXP |
Omeprazole affects the expression of MRO mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
|
|
G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
affects expression |
EXP |
Omeprazole affects the expression of MRPL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:14,333,233...14,337,006
Ensembl chr 9:14,333,234...14,337,040
|
|
G |
mrpl9 |
mitochondrial ribosomal protein L9 |
affects expression |
EXP |
Omeprazole affects the expression of MRPL9 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:182,082,012...182,086,758
Ensembl chr 2:182,076,369...182,087,095
|
|
G |
Mug2 |
murinoglobulin 2 |
affects expression |
EXP |
Omeprazole affects the expression of PZP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
|
|
G |
Myadm |
myeloid-associated differentiation marker |
affects expression |
EXP |
Omeprazole affects the expression of MYADM mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Mycbp2 |
MYC binding protein 2 |
affects expression |
EXP |
Omeprazole affects the expression of MYCBP2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
|
|
G |
Myo1d |
myosin ID |
affects expression |
EXP |
Omeprazole affects the expression of MYO1D mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
|
|
G |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
affects expression |
EXP |
Omeprazole affects the expression of NAA38 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
affects expression |
EXP |
Omeprazole affects the expression of NAP1L1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Nat8 |
N-acetyltransferase 8 |
affects expression |
EXP |
Omeprazole affects the expression of NAT8 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter] |
CTD |
PMID:21703235 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ndrg2 |
NDRG family member 2 |
affects expression |
EXP |
Omeprazole affects the expression of NDRG2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Ndufs5 |
NADH:ubiquinone oxidoreductase subunit S5 |
affects expression |
EXP |
Omeprazole affects the expression of NDUFS5 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:135,974,029...135,979,705
Ensembl chr 5:135,974,034...135,979,603 Ensembl chr14:135,974,034...135,979,603 Ensembl chr 2:135,974,034...135,979,603
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
affects expression |
EXP |
Omeprazole affects the expression of NDUFV3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Neu2 |
neuraminidase 2 |
affects expression |
EXP |
Omeprazole affects the expression of NEU2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:88,218,494...88,267,356
Ensembl chr 9:88,249,135...88,267,355
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] |
CTD |
PMID:27725188 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of NFKBIA protein] |
CTD |
PMID:32418911 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
affects expression |
EXP |
Omeprazole affects the expression of NFX1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
|
|
G |
Nipal2 |
NIPA-like domain containing 2 |
affects expression |
EXP |
Omeprazole affects the expression of NIPAL2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 7:65,774,477...65,884,807
Ensembl chr 7:65,774,477...65,884,807
|
|
G |
Nit1 |
nitrilase 1 |
affects expression |
EXP |
Omeprazole affects the expression of NIT1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein] |
CTD |
PMID:32418911 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
affects expression |
EXP |
Omeprazole affects the expression of NME2 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
EXP ISO |
Omeprazole results in increased expression of NQO1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 protein] |
CTD |
PMID:17202759 PMID:22687989 PMID:26272953 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO EXP |
[Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; NR1I2 protein affects the reaction [Omeprazole results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:12695340 PMID:17041008 PMID:25680588 PMID:26187274 PMID:27732639 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects expression increases expression decreases metabolic processing |
EXP ISO |
Omeprazole affects the expression of NR1I3 mRNA Omeprazole results in increased expression of NR1I3 mRNA NR1I3 gene mutant form results in decreased metabolism of Omeprazole |
CTD |
PMID:19118567 PMID:19483382 PMID:27434302 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects expression |
EXP |
Omeprazole affects the expression of NR3C1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Oaf |
out at first homolog |
affects expression |
EXP |
Omeprazole affects the expression of OAF mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
affects expression |
EXP |
Omeprazole affects the expression of OBP3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
affects expression |
EXP |
Omeprazole affects the expression of OGDH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Olr59 |
olfactory receptor 59 |
affects expression |
EXP |
Omeprazole affects the expression of OLR59 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Ostc |
oligosaccharyltransferase complex non-catalytic subunit |
affects expression |
EXP |
Omeprazole affects the expression of OSTC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
|
|
G |
Otc |
ornithine transcarbamylase |
affects expression |
EXP |
Omeprazole affects the expression of OTC mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
affects expression |
EXP |
Omeprazole affects the expression of PABPC4 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 5:135,563,142...135,578,985
Ensembl chr 5:135,563,562...135,578,979
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
affects expression |
EXP |
Omeprazole affects the expression of PAICS mRNA |
CTD |
PMID:19483382 |
|
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Omeprazole results in increased cleavage of PARP1 protein |
CTD |
PMID:15461867 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pc |
pyruvate carboxylase |
affects expression |
EXP |
Omeprazole affects the expression of PCX mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pccb |
propionyl-CoA carboxylase subunit beta |
affects expression |
EXP |
Omeprazole affects the expression of PCCB mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:101,590,737...101,641,234
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP ISO |
[Omeprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of PCNA protein]; Omeprazole promotes the reaction [Acetic Acid results in increased expression of PCNA protein] Omeprazole inhibits the reaction [Ethanol results in decreased expression of PCNA protein] |
CTD |
PMID:19251492 PMID:26970604 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
affects expression |
EXP |
Omeprazole affects the expression of PCSK6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
affects expression |
EXP |
Omeprazole affects the expression of PCTP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
|
|
G |
Pdcl3 |
phosducin-like 3 |
affects expression |
EXP |
Omeprazole affects the expression of PDCL3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 9:41,234,322...41,243,769
Ensembl chr 9:41,234,234...41,243,735
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
affects expression |
EXP |
Omeprazole affects the expression of PDIA3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
affects expression |
EXP |
Omeprazole affects the expression of PDIA6 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Pex19 |
peroxisomal biogenesis factor 19 |
affects expression |
EXP |
Omeprazole affects the expression of PEX19 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
affects expression |
EXP |
Omeprazole affects the expression of PGAM1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgrmc1 |
progesterone receptor membrane component 1 |
affects expression |
EXP |
Omeprazole affects the expression of PGRMC1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
affects expression |
EXP |
Omeprazole affects the expression of PHYH mRNA |
CTD |
PMID:19483382 |
|
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
|
|
G |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
affects expression |
EXP |
Omeprazole affects the expression of PIGP mRNA |
CTD |
PMID:19483382 |
|
NCBI chr11:33,682,943...33,689,111
Ensembl chr11:33,682,948...33,689,321
|
|
G |
Pklr |
pyruvate kinase L/R |
affects expression |
EXP |
Omeprazole affects the expression of PKLR mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
increases phosphorylation multiple interactions |
ISO |
Omeprazole results in increased phosphorylation of PLA2G4A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Omeprazole results in increased phosphorylation of PLA2G4A protein] |
CTD |
PMID:25797602 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
affects expression |
EXP |
Omeprazole affects the expression of PLBD1 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
|
|
G |
Plg |
plasminogen |
affects expression |
EXP |
Omeprazole affects the expression of PLG mRNA |
CTD |
PMID:19483382 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Pls3 |
plastin 3 |
affects expression |
EXP |
Omeprazole affects the expression of PLS3 mRNA |
CTD |
PMID:19483382 |
|
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
|
|
G |
Pon2 |
paraoxonase 2 |
affects expression |
| |